About the job
Zenas Bio is at the forefront of biopharmaceutical innovation, dedicated to transforming the lives of patients with autoimmune diseases through the development and commercialization of groundbreaking therapies. Our strategic approach leverages a seasoned leadership team and a meticulous product acquisition strategy to identify, acquire, and develop promising therapies worldwide. We are currently advancing two late-stage candidates: obexelimab and orelabrutinib. Obexelimab, our leading candidate, is a unique bifunctional monoclonal antibody targeting both CD19 and FcγRIIb to inhibit the pathological activity of B cells involved in autoimmune diseases, while preserving their presence. This innovative therapy is designed for self-administration via subcutaneous injection, offering a potentially effective solution for chronic autoimmune conditions. Meanwhile, orelabrutinib is a highly selective, oral Bruton’s Tyrosine Kinase (BTK) inhibitor with the potential to manage compartmentalized inflammation in Multiple Sclerosis (MS). Our earlier-stage pipeline includes a preclinical, oral IL-17AA/AF inhibitor and a brain-penetrant TYK2 inhibitor, both of which hold promise for advancing patient care.
We are on the lookout for exceptional talent who share our passion for patient care and have a proven record in product development and commercialization on a global scale. At Zenas, you will thrive in a dynamic learning environment, contributing to our mission of becoming a global leader in immunology and autoimmune disease treatment while embodying our core values of Transparency, Relationships, Urgency, Excellence, and Innovation – TRUE Innovation!
Position Summary:
The Senior Director of Regulatory Affairs (RA) will act as the Global Regulatory Lead for a multi-indication late-phase investigational product, overseeing global regulatory submissions in the US and EU, and contributing to the advancement of Phase 2 indications through clinical development planning. This role will also involve managing regulatory strategies for at least one early-phase investigational product, including the preparation and submission of IND/CTA/amendments and future marketing applications. The Senior Director will provide strategic guidance on regulatory submissions, responses, and essential regulatory intelligence, while collaborating with a diverse cross-functional team and key internal and external stakeholders.
